Dr. Peter Block and Dr. Deepak Bhatt discuss Dapagliflozin and Prevention of Adverse-Outcomes in HF Trial (DAPA-HF 0:50) and the Colchicine Cardiovascular Outcomes Trial (COLCOT 3:07).

Keywords: AHA Annual Scientific Sessions, AHA19, Dyslipidemias, Heart Failure, Acute Coronary Syndrome, Angina, Unstable, Colchicine, Diarrhea, Heart Arrest, Inflammation, Myocardial Infarction, Myocardial Revascularization, Percutaneous Coronary Intervention, Primary Prevention, Stroke, Benzhydryl Compounds, Glomerular Filtration Rate, Glucosides, Heart Failure, Hospitalization, Hypotension, Natriuretic Peptide, Brain, Peptide Fragments, Renal Insufficiency, Sodium-Glucose Transporter 2, Stroke Volume

< Back to Listings